No Data
No Data
Pulike Biological Engineering, Inc. (603566.SH) has accumulated a repurchase of 1.05% of its shares.
On August 19th, Gelonhui reported that up to August 19, 2024, pulike biological engineering,inc. (603566.SH) has accumulated repurchased 3.6247 million shares through centralized bidding trading, accounting for 1.05% of the company's total share capital, an increase of 0.143% compared with the last disclosed number. The highest repurchase price was 22.48 yuan/share, and the lowest was 11.93 yuan/share. The total amount paid was 54,235,340 yuan (excluding transaction fees).
Pulike Biological Engineering, Inc. (603566.SH) currently has a layout in areas such as pet vaccines, pharmaceuticals, and functional health products.
Pulike Biological Engineering, Inc. (603566.SH) stated on the investor interaction platform on August 7 that the company has layout in the areas of pet vaccines, pharmaceuticals, and functional health products and is promoting the ecological layout of the pet industry in multiple dimensions, including product research and development, achievement transformation, and market promotion.
Pulike Biological Engineering, Inc. (603566.SH): The African swine fever subunit vaccine has submitted an application for emergency evaluation.
On August 7th, Gelonhui reported that Pulike Biological Engineering, Inc. (603566.SH) stated on the investor interaction platform that the African swine fever subunit vaccine developed in cooperation with the Lanzhou Veterinary Research Institute of the Chinese Academy of Agricultural Sciences has submitted an emergency evaluation application and relevant work is underway.
Pulike Biological Engineering, Inc. (603566.SH): Currently, the company does not have any products related to small ruminant pestilence.
Pulike Biological Engineering, Inc. (603566.SH) stated on the investor interaction platform on August 7th that the company currently does not have any products related to small ruminant plague.
Pulike Biological Engineering, Inc. (603566.SH) has already repurchased 0.9% of its shares.
On August 1, Gelunhui reported that pulike biological engineering,inc. (603566.SH) has accumulated repurchased 3.1293 million shares through centralized bidding trading method until July 31, 2024. The repurchased shares account for 0.90% of the total share capital of the company, with the highest repurchase price at 22.48 yuan/share and the lowest at 11.93 yuan/share. The total amount paid, excluding transaction costs, is 48,274,320 yuan.
Pulike Biological Engineering Gets Certificate for Allergic Dermatitis Drug for Cats
No Data